JSJian-Lin Shen

Jian-Lin Shen

*This is an algorithmically generated author record based on publicly available information.

Jian-Lin Shen has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Transcriptomic and Proteomic Analyses Reveal the Anti–Ovarian Cancer Activity of Lotus Seedpod Polysaccharide on SKOV3 Cells via RIPK1/RIPK3/MLKL Pathway

    by Jin-Shi Chen, Jing Li, Xiao-Fan Lin, Yan-Ping Li, Jian-Lin Shen, Ao-Qiu Chen, Qi Zou, Jiang-Hong Luo, Xiao-Yin Wang

    This study aimed to investigate the anti–ovarian cancer activity of lotus seedpod polysaccharide (LSP) on human ovarian cancer SKOV3 cells and the relevant molecular mechanisms. The toxicity of LSP was also assessed in normal mice. The results showed that LSP inhibited SKOV3 proliferation and induced cell apoptosis. Transcriptomic and proteomic analyses indicated that LSP induced significant changes in gene and protein expressions, and their combined analysis showed necroptosis as one of the main pathways, which was confirmed by Hoechst 33342/PI double staining and western blot analysis. Moreover, LSPs significantly upregulated the protein expressions of RIPK1, phospho‐RIPK1, RIPK3, phospho‐RIPK3, MLKL, phospho‐MLKL, TNFRSF1A, FTH1, and FTL. Meanwhile, LSP increased ΔΨm loss and the ROS level in SKOV3 cells. Furthermore, LSP showed no acute toxicity to normal mice in the dose range of 50–450 mg/kg·bw. These results suggest that LSP is a safe active ingredient that exerts anti–ovarian cancer activity in SKOV3 cells by inhibiting proliferation, inducing cell apoptosis, and inducing necroptosis via the RIPK1/RIPK3/MLKL pathway. These findings are helpful to the application of LSP in anti–ovarian cancer and the high‐value utilization of lotus seedpod resources.